TradeOrgs
  • Stocks
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← All stocks

🇮🇳AARTIDRUGS

AARTIDRUGS

NSE
₹386.60
▲ ₹8.20 (+2.2%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 03 Jul 2026
H ₹425.30L ₹318.95-6.2%
₹425.3₹404.03₹382.76₹361.49₹340.22₹318.95₹386.6
RSI (14)
Intraday · 15-minBuy+20RSI 45UptrendMACD Bearishfor day-trading context — not advice

Technical signal

Neutral-10
RSI (14)61
oversold 30overbought 70
Trend
Sideways
MACD
Bullish
Bollinger
Above upper band
vs 20-day
above
vs 50-day
above
vs 200-day
below
Support
₹365.00
Resistance
₹394.85
  • Price is above its 50-day average (medium-term uptrend).
  • Price is above the upper Bollinger Band (stretched to the upside).

Signal backtest · 2025-09-29 → 2026-07-03

Strategy return
-15.0%
Buy & hold
-19.8%
Trades
6
Win rate
17%

₹1,00,000.00 invested would be worth ₹85,039.81 (-15.0%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Aarti Drugs Limited· Drug Manufacturers - Specialty & Generic

source: yahoo

Aarti Drugs Limited, through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company offers aceclofenac, celecoxib, diclofenac sodium, diclodenac potassium, diclofenac diethylamine, diclofenac resinate, diclofenac epolamine, nimesulide, ciprofloxacin HCL, enrofloxacin base, gatifloxacin sesquihydrate, levofloxacin base, norfloxacin, ofloxacin, metronidazole, metronidazole benzoate, ornidazole, secnidazole, tinidazole, clopidogrel bisulphate, ticlopidine HCL, metformin HCL, pioglitazone HCL, teneligliptin, vildagliptin, fluconazole, ketoconazole, tolnaftate, zolpidem tartrate, niacin, raloxifene HCL, and acamprosate. It also provides benzene sulphonyl chloride, benzene sulphonic acid, methyl benzenesulfonate, sodium benzene sulfinate, para toluene sulphonyl chloride, methyl para toluenesulfonate, sodium para toluenesulfinate, para chlorobenzenesulfonyl chloride, formamide, calcium fluoride, potasium formate, benzenesulfonamide, ethyl p- toluenesulfonate, N,N',N'-tris-(4-toluene sulfonyl)-diethylenetriamine, ortho para toluene sulfonamides, ortho para toluene sulfonamides acid methyl ester, para chlorobenznesulfonamide, para toluenesulfonyl hydrazide, para toluenesulfonamide, and sodium benzenesulfonate. In addition, it offers pharma intermediate products, which includes Celecoxib, Ciprofloxacin, Clopidogrel, Diclofenac, Ketoconazole, Nimesulide, Raloxifene, Tinidazole, and Zolpidem. Further, the company develops drugs for antifungal, cardiovascular, and antidiabetic therapeutic areas, as well as non-steroidal anti-inflammatory drugs. The company was incorporated in 1984 and is headquartered in Mumbai, India.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Mumbai, India
www.aartidrugs.co.in ↗

Fundamentals

source: yahoo
Market cap
₹3.53KCr
P/E
18.1
P/B
2.3
EPS
₹21.38
Div yield
0.5%
Profit margin
7.6%
ROE
13.4%
Debt / Equity
0.37
Beta
0.35
52-week range
₹318.95 – ₹564.05
52-week low · ₹318.9528% of rangehigh · ₹564.05

Fundamental data is informational only — not investment advice.

Recent news

News sentiment:— Neutral1↑ · 1↓ · 6–
  • Tennessee deputy spent seized drug money on Apple gear for his family — now he owes $339K in pension clawbacks— Neutral
    Moneywise · 04 Jul 2026
  • Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done”— Neutral
    Insider Monkey · 04 Jul 2026
  • Jim Cramer Says He Bets “The Gains in CVS Will Be Long-Lasting”▲ Positive
    Insider Monkey · 04 Jul 2026
  • Jim Cramer Says He Would Avoid Blue Owl and Prefers Blackstone

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

— Neutral
Insider Monkey · 04 Jul 2026
  • Jim Cramer on Palantir: “This Is the Fastest Grower of the Stocks I Follow, and It’s Been Crushed”— Neutral
    Insider Monkey · 04 Jul 2026
  • EPR's CFO Sold Shares at a Premium — Here's the Bet Behind the Stock— Neutral
    Motley Fool · 04 Jul 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.